STAA shares were up 11% at $70.91 per share as the market opened today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down 0.4%.
The Lake Forest, California-based ocular implant company posted profits of $9.6 million, or 19¢ per share, on sales of $63.2 million for the three months ended April 1, 2022, for a 92.3% bottom-line gain on sales growth of 24.5%.
Adjusted to exclude one-time items, earnings per share were 29¢, 14¢ ahead of Wall Street, where analysts were looking for sales of $60.5 million.
“Our first quarter results represent a new record for quarterly net sales and quarterly ICL units as we successfully raise surgeon and patient awareness and enthusiasm for the Visual Freedom provided by our proprietary Evo Visian ICL …